HomeThemesTypesDBAbout
Showing: ◈ news×◈ cancer×
‘The medicines supply chain is broken at every level,’ warns Dr Leyla Hannbeck.
British pharmacists are struggling to get their hands on certain medicines for cancer, epilepsy, diabetes and menopause as drug supply issues intensify in the country.
With an estimated one million cancer diagnoses missed across Europe in the last two years, the impact of the COVID-19 pandemic is predicted to set back European cancer outcomes... / The study also finds Brexit will continue to negatively impact European cancer research unless European funders/research community and the UK government/research community find a way for continued collaboration.
Controversial Tory bill set to inflict further damage on businesses, with no clues yet about incoming legislation.
Four international scientists explain how a grant debacle stemming from Brexit has affected their research and career plans. / UK science suffered a significant setback in June, when the European Research Council (ERC) confirmed that 143 UK-based researchers would forfeit their prestigious ERC grants unless they relocated to a country in the European Union.
The warning comes after a Glasgow-based, world-leading cancer expert said he was considering moving a major research project abroad because of a Brexit-linked impasse over EU funding.
One of Scotland’s top cancer experts is considering moving a major research project abroad amid political turmoil and warnings that a Brexit-linked impasse over EU funding will starve universities of talent.
NICOLA Sturgeon has said Brexit is making recruitment of oncologists and radiologists "more challenging" as she was pressed on NHS waiting times by Douglas Ros at FMQs.
Two in three British pharmacies are struggling daily to source painkillers, cancer drugs and other vital medicines, research shows, as the availability of pharmaceuticals becomes increasingly uncertain.
A terminal cancer patient has been handed a hefty tax bill for her "miracle" lifesaving drugs, because of changes to how VAT is charged post-Brexit.
RESEARCH experts and charities working with people with serious and often terminal illnesses have said that delays to research and clinical trials from Brexit could mean the difference between "life or death" for patients.
Informa Pharma Intelligence (IPI) has found that some drug firms may withdraw up to 90% of their products from Northern Ireland, once the Brexit grace period has passed.
Brexit has delayed Northern Ireland’s right to use a life-saving cancer drug in the same way as the UK.
BREXIT red tape is leading to the withdrawal of vital drugs from Northern Ireland due to the high costs for manufacturers, an industry chief has warned.
Firms already starting to withdraw vital drugs because of costly new red tape, says industry group.
A senior Conservative MP has told PoliticsHome that he will be "seeking urgent clarification from the government" over reports time-sensitive cancer drugs were destroyed due to post-Brexit border delays.
Head of Welsh CBI tells committee pharmaceutical firm has had to move production to Dublin.
UK researchers fear being blocked from EU-wide testing of treatments for diseases including rare childhood cancers.
'Given the dangers, every possible step must be taken to avoid it.'
Government concedes that it 'will not be practical to stockpile products to cover expected delays of up to six months'.
A previously confidential government study detailing 142 areas of life in Northern Ireland that will be impacted by Brexit has been published, revealing risks to everything from cooperation on congenital heart disease and cross-border child protection to rules preventing the looting of national treasures.
A British pensioner battling an aggressive form of cancer has told of his fears for the future over health coverage for Britons in France.
Analysis finds changes such as removal of blanket ban on hormone-disrupting chemicals. / The UK has been accused of “silently eroding” key environmental and human health protections in the Brexit-inspired rush to convert thousands of pages of European Union pesticide policy into British law.
Hospitals are likely to experience delays to cancer testing and treatment regardless of the result of next week's Brexit vote, BBC Newsnight has learned.
Universities have warned ministers of the risks to research, staff and students if Britain crashes out of the EU without a deal. Higher education bosses said a “no-deal” Brexit would “compromise” vital studies into cancer treatments and climate change.